News Releases

Latest News

AbD Serotec Joins Bio-Rad Laboratories
Feb 26, 2013
Bio-Rad Laboratories, Inc. recently completed the acquisition of AbD Serotec, formerly a division of MorphoSys AG. Bio-Rad has remained at the center of scientific discovery for more than 50 years, manufacturing and distributing a broad range of products for the life science research and clinical diagnostic markets.
Bio-Rad Acquires AbD Serotec
Jan 10, 2013
HERCULES, CA – January 10, 2013 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced that it has purchased AbD Serotec, a division of MorphoSys AG, for approximately 53 million euros in cash.
AbD Serotec Licenses HuCAL Antibodies to DiaSorin for Use in Clinical Diagnostic Assays for Infectious Disease Testing
Oct 16, 2012
16 October 2012: MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced today that DiaSorin S.p.A., a worldwide provider of specialty assays, has taken a license for two recombinant HuCAL antibodies.
AbD Serotec Introduces Bovine and Ovine Dendritic Cell Growth Kits and Antibodies
Jul 10, 2012
Oxford, UK, 10 July 2012: AbD Serotec, a leader in antibody products for veterinary research, has today announced that it has launched bovine and ovine Dendritic Cell Growth Kits and a complementary panel of antibodies for dendritic cell phenotyping.
AbD Serotec to Launch Panel of HuCAL Anti-Drug Antibodies..
May 23, 2012
Launch Panel of HuCAL Anti-Drug Antibodies